cell
divis
cycl
gene
product
member
famili
rho
gtpase
small
g
protein
rhofamili
belong
ra
superfamili
small
gtpase
rhofamili
gtpase
broad
spectrum
physiolog
function
cell
cycl
regul
includ
establish
control
cell
actin
cytoskeleton
vesicl
traffick
cell
polar
cell
prolifer
motil
migrat
transcript
activ
reactiv
oxygen
speci
product
tumorigenesi
signal
regulatori
function
base
tightli
regul
cycl
activ
gtp
bind
inact
state
gtp
hydrolysi
intric
interact
multipl
protein
impact
cell
function
activ
state
shown
play
number
physiolog
pivot
tissuespecif
role
cardiovascular
genitourinari
respiratori
nervou
immun
system
dysfunct
implic
background
syndrom
immunodefici
immun
dysregul
patient
report
far
first
report
pediatr
patient
syndrom
immunodefici
autoinflamm
hemophagocyt
lymphohistiocytosi
malign
lymphoprolifer
novel
heterozyg
mutat
gene
found
report
case
boy
refer
pneumonolog
allergolog
clinic
immunolog
unit
poznan
pediatr
univers
hospit
pneumonia
bilater
otiti
media
vesicular
dermat
sinc
age
year
suffer
recurr
respiratori
tract
infect
requir
multipl
hospit
recurr
bronchiti
pneumonia
maxillari
sinus
otiti
media
purul
dermat
pseudomona
aeruginosa
staphylococcu
aureu
infect
sever
varicella
complic
pneumonia
sinus
gastrointestin
infect
complet
full
cours
vaccin
includ
bcg
bacil
mmr
vaccin
without
advers
effect
follow
immun
aefi
famili
histori
complic
multipl
sclerosi
patient
father
present
neurodevelopment
delay
dysmorph
featur
obliqu
palpebr
fissur
eyebrow
retrognathia
low
set
small
auricl
thick
helic
clinodactyli
v
finger
erythemat
papulovesicular
rash
present
skin
face
perior
region
retroauricular
area
nasopharynx
oral
caviti
inflammatori
lesion
observ
strike
symptom
lymphadenopathi
numer
bilater
enlarg
cervic
submandibular
lymph
node
hospit
requir
antibiot
therapi
bilater
paracenthesi
tympanostomi
drainag
maxillari
sinus
laboratori
evalu
reveal
antibodi
product
defect
memori
b
cell
defici
therefor
replac
therapi
intraven
immunoglobulin
ivig
initi
genet
test
recommend
patient
receiv
three
ivig
transfus
monthli
interv
afterward
parent
decid
discontinu
therapi
boy
lost
followup
age
year
boy
refer
clinic
recurr
fever
accompani
vomit
abdomin
pain
cervic
lymphadenopathi
splenomegali
episod
fever
start
month
hospit
associ
sign
symptom
infect
would
reach
degre
respond
treatment
antibiot
time
famili
member
ill
boy
contact
toxic
substanc
infect
travel
mediterranean
exot
region
laboratori
test
show
pancytopenia
lymphopenia
neutropenia
high
inflammatori
marker
hypoalbuminemia
igg
igm
hypoimmunoglobulinemia
hyperferritinemia
hypertriglyceridemia
hypertransaminasemia
posit
ebvdna
copiesml
peripher
blood
laboratori
find
compris
markedli
elev
uml
serum
concentr
solubl
interleukin
receptor
decreas
intracellular
express
perforin
nk
cell
increas
cell
concomitantli
neither
bone
marrow
lymph
node
sign
hemophagocytosi
found
henc
seven
eight
diagnost
criteria
four
clinic
three
immunolog
criteria
hemophagocyt
lymphohistiocytosi
hlh
fulfil
data
display
tabl
concern
sever
respiratori
infect
figur
sepsi
immunocompromis
patient
initi
empir
pharmacotherapi
base
broad
spectrum
antibiot
meropenem
vancomycin
pneumocysti
jiroveci
prophylaxi
cotrimoxazol
antivir
antimycot
medic
acyclovir
fluconazol
chemoimmunotherapi
hlh
initi
methylprednisolon
puls
therapi
etoposid
cyclosporin
boy
also
requir
supplement
transfus
albumin
immunoglobulin
prothrombin
complex
red
blood
cell
prepar
initi
respons
therapi
satisfactori
improv
patient
gener
state
resolut
fever
decreas
serum
inflammatori
marker
subsequ
howev
boy
state
deterior
febril
episod
return
exacerb
supraclavicular
abdomin
lymphadenopathi
observ
figur
base
complex
diagnost
procedur
includ
histopatholog
immunolog
magnet
reson
imag
mri
diagnosi
iv
stage
nodular
sclerosi
ns
hodgkin
lymphoma
establish
boy
underw
success
chemotherapi
base
euronet
pediatr
hodgkin
lymphoma
protocol
includ
oepa
vincristin
etoposid
prednison
doxorubicin
follow
emiss
tomographycomput
tomographi
fdgpetct
reevalu
consider
decis
regard
therapeut
option
includ
bone
marrow
transplant
ongo
search
genet
caus
hlh
syndrom
immun
defici
autoinflamm
recurr
fever
whole
exom
sequenc
we
dna
extract
peripher
blood
perform
enrich
sureselectxt
human
exon
agil
use
sequenc
perform
illumina
platform
hiseq
bioinformat
analysi
perform
previous
describ
modif
version
human
genom
refer
sequenc
use
align
detail
we
result
variant
filter
given
supplementari
materi
priorit
heterozyg
missens
variant
gene
c
variant
report
previous
found
gnomad
databas
http
gnomadbroadinstituteorg
inhous
databas
polish
exom
variant
predict
pathogen
mutat
taster
mutat
assessor
fathmmmkl
fathmmxf
lrt
eigen
eigen
pc
sift
provean
mvp
revel
primateai
metasvm
metalr
wherea
fathmm
suggest
toler
http
varsomecom
cadd
score
indic
pathogen
notabl
altern
variant
amino
acid
posit
g
classifi
like
pathogen
associ
syndrom
clinvar
http
wwwncbinlmnihgovclinvar
fragment
gene
encompass
variant
pcramplifi
analyz
method
deep
amplicon
sequenc
ad
proband
parent
presenc
variant
confirm
proband
exclud
parent
indic
variant
occur
de
novo
accord
acmg
recommend
variant
classifi
like
pathogen
base
follow
criteria
variant
result
de
novo
mutat
patient
famili
histori
pathogen
strong
variant
found
gnomad
data
pathogen
moder
altern
variant
amino
acid
posit
classifi
like
pathogen
clinvar
pathogen
moder
multipl
line
comput
evid
support
deleteri
effect
pathogen
support
broad
spectrum
heterogen
clinic
manifest
disturb
molecul
regul
result
wide
varieti
cellular
pathway
activ
mammalian
model
shown
play
fundament
role
cell
biolog
implic
wide
array
physiolog
pivot
tissuespecif
activ
organogenesi
cellular
specif
migrat
function
matur
cardiovascular
system
pancrea
kidney
lung
salivari
mammari
gland
central
nervou
system
skin
bone
sensori
organ
inner
ear
photoreceptor
import
clinicopatholog
issu
role
gtpase
hematopoiesi
immun
system
homeostasi
control
multilineag
develop
blood
progenitor
egress
bone
marrow
peripheri
influenc
tight
balanc
myelopoiesi
erythropoiesi
contribut
immun
system
regul
coordin
surviv
prolifer
migrat
receptor
express
activ
signal
transduct
cytokin
secret
b
cell
dysregul
actin
dynam
may
therefor
imped
multipl
stage
b
cell
develop
affin
matur
result
aberr
germin
center
respons
immunodefici
autoimmun
lymphoprolifer
patient
studi
novel
heterozyg
de
novo
mutat
gene
identifi
first
time
mark
complex
clinic
phenotyp
observ
character
syndrom
featur
neurodevelopment
delay
immunodefici
autoinflamm
hemophagocyt
lymphohistiocytosi
malign
lymphoprolifer
clinic
phenotyp
patient
gene
mutat
triad
recogniz
symptom
macrothrombocytopenia
development
delay
distinct
facial
featur
initi
describ
takenouchi
kosaki
worth
note
initi
report
patient
syndrom
mutat
present
divers
clinic
manifest
observ
patient
variant
sinc
immunodefici
system
autoinflammatori
diseas
hlh
lymphoma
present
origin
case
evid
support
notion
gene
mutat
caus
syndrom
form
thrombocytopenia
also
provid
takenouchi
et
al
motokawa
et
al
report
next
two
patient
share
variant
overlap
phenotyp
includ
facial
dysmorph
psychomotor
development
delay
lymphedema
lower
extrem
camptodactyli
sensorineur
hear
loss
immunodefici
evid
intric
relationship
heterogen
clinic
featur
correl
mutat
affect
gene
provid
martinelli
et
al
author
report
patient
divid
three
group
accord
differ
diseasecaus
mutat
name
group
group
group
variou
mutat
relat
unusu
broad
spectrum
anomali
predomin
growth
retard
development
disord
intellectu
disabl
macrothrombocytopenia
note
foremostli
group
patient
variant
affect
amino
acid
novel
report
sever
autoinflammatori
diseas
lymphohistiocyt
hemophagocytosi
lymphoprolifer
present
contrast
patient
classic
syndrom
similarli
patient
system
autoinflammatori
diseas
develop
hlh
predomin
manifest
four
patient
three
distinct
ctermin
de
novo
variant
p
report
gernez
et
al
likewis
four
patient
disturb
hematopoiesi
rash
autoinflamm
hlh
report
lam
et
al
share
ctermin
variant
gene
two
latter
studi
point
uniqu
effect
ctermin
mutat
result
neonatalonset
deregul
inflammatori
respons
develop
secondari
hlh
patient
present
symptom
signific
autoinflammatori
diseas
hlh
earli
childhood
may
assum
hlh
might
secondari
set
autoinflamm
malign
transform
sinc
play
pivot
role
tight
regul
plethora
complex
cell
function
deregul
result
impair
cell
prolifer
migrat
transcript
program
shown
oncogen
overexpress
report
sever
cancer
includ
nonsmal
cell
lung
cancer
colorect
adenocarcinoma
melanoma
breast
cancer
testicular
cancer
support
role
promot
tumorigenesi
oncogen
modul
transcript
factor
signal
transduc
activ
transcript
nuclear
factor
turn
regul
cancer
cell
growth
surviv
well
alter
cancer
cell
metabol
mechan
activ
contribut
malign
cell
transform
numer
somat
genet
alter
affect
describ
human
lymphoma
mutat
may
play
role
genesi
lymphoma
may
assum
hematopoiet
stem
cell
transplant
would
cur
strategi
patient
howev
whether
develop
hodgkin
lymphoma
report
patient
may
mechanist
connect
novel
variant
requir
investig
describ
novel
heterozyg
mutat
gene
encod
small
gtpase
rho
subfamili
play
pivot
role
cell
cycl
regul
patient
studi
divers
clinic
manifest
compos
syndrom
phenotyp
facial
dysmorph
neurodevelopment
delay
immunodefici
autoinflamm
hemophagocyt
lymphohistiocytosi
malign
lymphoprolifer
share
common
featur
syndrom
patient
ctermin
mutat
worth
note
hodgkin
lymphoma
describ
first
time
patient
mutat
may
therefor
assum
differ
diseasecaus
mutat
differ
impact
gtpase
structur
activ
bind
effector
final
heterogen
clinic
manifest
affect
patient
lead
new
challeng
syndrom
recognit
delin
raw
data
support
conclus
articl
made
avail
author
without
undu
reserv
qualifi
research
ethic
review
approv
requir
studi
human
particip
accord
local
legisl
institut
requir
written
inform
consent
particip
studi
provid
particip
legal
guardiannext
kin
written
inform
consent
obtain
parent
public
case
report
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
